Amino 1,2,4-triazole derivatives as modulators of mGluR5

Details for Australian Patent Application No. 2008317544 (hide)

Owner AstraZeneca AB

Inventors Wallberg, Andreas; Isaac, Methvin

Agent Freehills

Pub. Number AU-A-2008317544

PCT Pub. Number WO2009/054794

Priority 60/982,956 26.10.07 US

Filing date 23 October 2008

Wipo publication date 30 April 2009

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/054794 Priority application(s): WO2009/054794

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008317548-Variable-size bed

2008317533-Telemedicine care